FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37669836> ?p ?o ?g. }

• Q37669836 description "2017 ജനുവരി 4 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
• Q37669836 description "article científic" @default.
• Q37669836 description "article scientifique" @default.
• Q37669836 description "articolo scientifico" @default.
• Q37669836 description "artigo científico" @default.
• Q37669836 description "artículu científicu espublizáu en 2017" @default.
• Q37669836 description "bilimsel makale" @default.
• Q37669836 description "scientific article published on 04 January 2017" @default.
• Q37669836 description "vedecký článok" @default.
• Q37669836 description "vetenskaplig artikel" @default.
• Q37669836 description "videnskabelig artikel" @default.
• Q37669836 description "vědecký článek" @default.
• Q37669836 description "wetenschappelijk artikel" @default.
• Q37669836 description "wissenschaftlicher Artikel" @default.
• Q37669836 description "наукова стаття, опублікована в січні 2017" @default.
• Q37669836 description "научни чланак" @default.
• Q37669836 description "مقالة علمية نشرت في 04 يناير 2017" @default.
• Q37669836 name "The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies" @default.
• Q37669836 name "The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies" @default.
• Q37669836 name "The Oral β-Lactamase SYN-004" @default.
• Q37669836 type Item @default.
• Q37669836 label "The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies" @default.
• Q37669836 label "The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies" @default.
• Q37669836 label "The Oral β-Lactamase SYN-004" @default.
• Q37669836 prefLabel "The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies" @default.
• Q37669836 prefLabel "The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies" @default.
• Q37669836 prefLabel "The Oral β-Lactamase SYN-004" @default.
• Q37669836 P1433 Q37669836-CC22753C-E2D4-4BCB-A523-E8937D7F2471 @default.
• Q37669836 P1476 Q37669836-B06BC952-60EC-41BD-8CF8-725BAD7FB3AF @default.
• Q37669836 P2093 Q37669836-01C82AAF-2285-4592-B428-E475C1EED701 @default.
• Q37669836 P2093 Q37669836-068A2961-EF96-41FA-B7DA-419B39D0E867 @default.
• Q37669836 P2093 Q37669836-2BBCAFC0-3CE0-4466-B182-C97951A924D8 @default.
• Q37669836 P2093 Q37669836-652F32F9-A7DF-473E-ACBB-9074C651BB1F @default.
• Q37669836 P2093 Q37669836-8443CE95-0BF8-458D-BEAA-7C3889A1B6CF @default.
• Q37669836 P2093 Q37669836-A7A23DBB-6371-48B6-AADC-CE58799BD964 @default.
• Q37669836 P2093 Q37669836-B5F95EC0-49B7-4F00-8D38-2D4C00522A9A @default.
• Q37669836 P2093 Q37669836-E01CA13A-B9B1-4488-9175-CF2639992373 @default.
• Q37669836 P2093 Q37669836-E1651081-5BF1-4774-8012-9AD418877D6A @default.
• Q37669836 P2093 Q37669836-E962AB61-EBDE-4742-BAA8-297482EFAC7F @default.
• Q37669836 P2860 Q37669836-0274AF07-83BA-48F7-98FE-F47D8F698A71 @default.
• Q37669836 P2860 Q37669836-069ACEEA-7951-41AC-9C69-83E76345F174 @default.
• Q37669836 P2860 Q37669836-0ACF4D38-886B-4C9D-BD22-8923C5BBBA51 @default.
• Q37669836 P2860 Q37669836-0C02CB61-3E53-45D2-9E0E-164D6A3943FD @default.
• Q37669836 P2860 Q37669836-177FC9F5-E83B-4D94-8B35-12E1E121AC9A @default.
• Q37669836 P2860 Q37669836-23FC671C-09B3-499E-94DA-8D7048F4B71F @default.
• Q37669836 P2860 Q37669836-2A8CE055-2EF9-4484-BFC0-3BBDC1063931 @default.
• Q37669836 P2860 Q37669836-34366CA3-867E-45DF-B793-51110A55F42D @default.
• Q37669836 P2860 Q37669836-3451E830-333B-4CC9-8DC9-EDC3D8A6C3A4 @default.
• Q37669836 P2860 Q37669836-36474EE7-79AB-4E9D-BF82-7A4D011011A0 @default.
• Q37669836 P2860 Q37669836-3671F66F-3BF0-49EF-9A14-60DF2791461F @default.
• Q37669836 P2860 Q37669836-373BFCD1-4371-46F2-BE12-EE6A4E04DDD0 @default.
• Q37669836 P2860 Q37669836-44C1D10A-2ADE-4359-816F-0D3F08DBE268 @default.
• Q37669836 P2860 Q37669836-48F0B895-796C-4F5E-AD76-7F39B2FDB937 @default.
• Q37669836 P2860 Q37669836-4CAC3434-98E4-4955-9CB3-672EEA841740 @default.
• Q37669836 P2860 Q37669836-5A096E4A-9A04-4D32-8A98-3BDE29DECC2B @default.
• Q37669836 P2860 Q37669836-5B575311-419A-4CBE-B973-17164B384A24 @default.
• Q37669836 P2860 Q37669836-7A7EEFA7-3F06-4542-B43E-6BE62569EC75 @default.
• Q37669836 P2860 Q37669836-83660FB2-6794-4217-A7B2-B66B4DA2A62C @default.
• Q37669836 P2860 Q37669836-8BC8C843-2F0A-4B6E-B762-23AF4DE99DB5 @default.
• Q37669836 P2860 Q37669836-8DC7B8F0-94DC-43F4-947A-06BA2D899665 @default.
• Q37669836 P2860 Q37669836-935A2F88-F5D4-4B8B-9BB0-C74CDBC66B1C @default.
• Q37669836 P2860 Q37669836-9486104F-88AA-4E2E-83E9-AC8170B08785 @default.
• Q37669836 P2860 Q37669836-9677FA91-EA9D-461D-9ED0-9DA0701341FF @default.
• Q37669836 P2860 Q37669836-9CEDD367-6EF4-41F9-A918-A983C17FF7F1 @default.
• Q37669836 P2860 Q37669836-AE8C583D-6085-44B6-9E13-869A73EF5155 @default.
• Q37669836 P2860 Q37669836-C4F35803-E5A8-461E-8C19-E08265491198 @default.
• Q37669836 P2860 Q37669836-C6839E25-8EBA-4DD3-B0A5-46D1278012A9 @default.
• Q37669836 P2860 Q37669836-C713B554-B53E-41B0-B315-503D7BEA80C5 @default.
• Q37669836 P2860 Q37669836-C8C8EAF6-B624-4F81-9F99-718E8E7E7444 @default.
• Q37669836 P2860 Q37669836-CAB83B1E-99D6-4FBC-B6A1-EFA733D6DFB1 @default.
• Q37669836 P2860 Q37669836-D1CCC80F-A713-4A03-A982-F3AC2E3D6732 @default.
• Q37669836 P2860 Q37669836-D59C6E07-3471-404D-A17F-4F26F2A095A8 @default.
• Q37669836 P2860 Q37669836-D61AB05C-EC15-4022-B7F6-8FFDA8388AE5 @default.
• Q37669836 P2860 Q37669836-D990B523-0183-4A1E-AB5D-D7D8E5112DD7 @default.
• Q37669836 P2860 Q37669836-DBE6AF56-288A-455A-9327-A83F008AD81F @default.
• Q37669836 P2860 Q37669836-DD48705C-3359-4E79-A92E-4FF8E095F9E4 @default.
• Q37669836 P31 Q37669836-7578C46E-D7BA-46E2-A06F-C66BA1023EF9 @default.
• Q37669836 P356 Q37669836-A7EA566F-4AA6-4E12-A6E3-D9C85AB73B4D @default.
• Q37669836 P407 Q37669836-45E12055-6718-47DB-9342-BE835B1AB93C @default.
• Q37669836 P433 Q37669836-2453C244-A085-45F5-879D-70C76A2274D0 @default.
• Q37669836 P478 Q37669836-514D2223-05E7-4360-A035-673B776A5256 @default.
• Q37669836 P50 Q37669836-7A0234D4-58DA-41DB-BA23-48F35F85D8B7 @default.
• Q37669836 P577 Q37669836-AAABA5C9-517F-43D4-828E-1DA418216E72 @default.
• Q37669836 P698 Q37669836-474B981E-BE53-41A8-BA82-62F107DDBDA1 @default.
• Q37669836 P921 Q37669836-7F235FF2-7BDC-40F1-B899-44A0AC4A4A92 @default.
• Q37669836 P932 Q37669836-EEB8E9BA-4703-473F-BC7D-BECA89DB274B @default.
• Q37669836 P356 AAC.02197-16 @default.
• Q37669836 P698 28052855 @default.
• Q37669836 P1433 Q578004 @default.
• Q37669836 P1476 "The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies" @default.
• Q37669836 P2093 "Christian Carter" @default.
• Q37669836 P2093 "Eric Sicard" @default.
• Q37669836 P2093 "Heidi Whalen" @default.
• Q37669836 P2093 "James Longstreth" @default.
• Q37669836 P2093 "Joseph Sliman" @default.
• Q37669836 P2093 "Marianne Rufiange" @default.
• Q37669836 P2093 "Marijke H Adams" @default.
• Q37669836 P2093 "Olivia Coughlin" @default.
• Q37669836 P2093 "Richard Fedorak" @default.
• Q37669836 P2093 "Tracey Roberts" @default.

• next